Chamber and committees

The Scottish Executive collectsdetails on each application made to local authorities under the homelessness legislation.However, these data are not collected in a way which allows a meaningful breakdownby parliamentary constituency. Annual figures on the numbers assessed as homelesscan be found online in the publications section of the housing statistics websitewww.scotland.gov.uk/stats/housing/hsbref.The most recent figures are for 2004-05 (published in Statistical Bulletin: Housing Series: HSG/2005/6: Operationof the Homeless Persons legislation in Scotland: national and local authority analyses 2004-05). Figuresfor 2005-06 will be published later this year.

The regulation and safety ofmedicines are reserved and are the responsibility of the Medicines and Healthcareproducts Regulatory Agency (MHRA). The MHRA and the Commission on Human Medicinesrun the UK’s spontaneous adverse drug reaction reporting scheme, the Yellow Card Scheme.

The Scottish Executive does nothold information on the number of reports of suspected adverse drug reactions receivedvia the Yellow Card Scheme.

The MHRA publishes on its websiteanonymised aggregated reports of suspected adverse drug reactions broken down bydrug and by reporter type. Data which provide a greater level of detail and whichcould potentially lead to the identification of individual reporters or patientsrequire an application to the Independent Scientific Advisory Committee. Applicationforms can be found on their website www.mhra.gov.uk.

The Information requested isshown in the following table. The increase in the numbers of patients, over theperiod, with a diagnosis of adverse drug reactions may, in part, be explained byimprovements in the recording of secondary diagnoses in recent years. Data priorto 1997 has not been included in the table because the different coding structureused to collect it does not allow for a direct comparison.

Acute Hospital (Non-Obstetric,Non-Psychiatric) In-Patient and Day Case Discharges with any Diagnosis of AdverseDrug Reactions^{1, 2, 3, 4, 5}: by NHS Board of Residence – Years Ending31 March 1997 to 2005

Year of Discharge

NHS Board/Area of Residence	1997	1998	1999	2000	2001	2002	2003	2004	2005
Argyll and Clyde	296	323	478	565	537	490	592	493	517
Ayrshire and Arran	298	310	438	503	540	617	531	462	483
Borders	45	48	70	83	84	101	97	88	88
Dumfries and Galloway	206	220	206	230	235	269	314	325	293
Fife	316	317	343	408	439	470	448	494	608
Forth Valley	163	167	190	206	206	155	167	184	275
Grampian	491	624	598	567	582	577	613	748	669
Greater Glasgow	899	989	988	971	1075	858	813	820	828
Highland	117	133	126	161	127	159	124	151	240
Lanarkshire	276	278	359	304	344	378	331	339	367
Lothian	769	880	941	900	972	859	1,115	1,247	1,343
Orkney	15	16	20	8	7	13	15	19	15
Shetland	11	17	20	16	19	24	10	29	23
Tayside	212	263	262	328	352	408	402	367	364
Western Isles	9	7	42	40	42	26	28	28	43
Scotland Residents Total	4,123	4,592	5,081	5,290	5,561	5,404	5,600	5,794	6,156
Outwith Scotland and not known	44	57	42	44	34	52	53	44	54

Notes:

1. These statistics arederived from data collected on discharges from non-obstetric andnon-psychiatric hospitals (SMR01) in Scotland

2. Up to six diagnoses (oneprincipal, five secondary) are recorded on SMR01 returns. All six diagnoseshave been used to select adverse drug reactions. All codes were selected fromthe International Statistical Classification of Diseases and Other HealthRelated Problems, tenth revision (ICD10):

3. Adverse drug reactionscan be the reason for admission to a hospital or can have occurred whilst inhospital as a result of medication.

4. Please note it is notpossible to distinguish between prescribed and non-prescribed drugs.

5. A patient will be countedonce in each year. Patients may be counted more than once across years.

I have asked Angiolina Foster, Chief Executive of Communities Scotland, to respond. Her response is asfollows:

The approval of RegenerationOutcome Agreements (ROAs) in October 2005 meets our Partnership Agreement commitmentto merge Social Inclusion Partnerships (SIPs) with Community PlanningPartnerships (CPPs).

The Community RegenerationFund (CRF), which replaced SIP funding from April 2005, is allocated toCommunity Planning Partnerships and targeted principally on the basis of the Scottish Index of Multiple Deprivation 2004.

Dundee CPP has five keyareas which it is targeting as follows:

CRA 1 – Menzieshill(part),Charleston,Lochee and Beechwood.

CRA 2 – St Mary’s, Ardlerand Kirkton.

CRA 3 – Hilltown, Stobswelland Fairmuir.

CRA 4 – Mill o Mains,Fintry(part) and Whitfield (part).

CRA 5 – Mid Craigie,Linlathen and Douglas.

In line with the guidance onROAs, Dundee CPP is also targeting on a thematic basis two communities ofinterest: vulnerable young people and young carers.

The information requested ispublished in Table 40 of Road Accidents Scotland 2004, copies of whichare available in the Scottish Parliament Information Centre (Bib .number38777). The table gives the figures for each year from 1995 to 2004.

The provisional numbers ofroad accidents and casualties for 2005 will be published on Thursday 15th June 2006.

I have asked Angiolina Foster, Chief Executive of Communities Scotland, to respond. Her response is asfollows:

The Social InclusionPartnership Fund was replaced by the Community Regeneration Fund (CRF) fromApril 2005. The selection of actual projects is managed locally by CommunityPlanning Partnerships (CPPs). Based on the grant claims submitted by all 32CPPs, over 1,300 projects were supported from the new CRF in 2005-06.

I have asked Angiolina Foster, Chief Executive of Communities Scotland, to respond. Her response is asfollows:

This information is not heldcentrally.

This information is not heldcentrally.

I have asked Angiolina Foster, Chief Executive of Communities Scotland, to respond. Her response is asfollows:

The Social InclusionPartnership (SIP) funding allocated to Dundee since 1999 is as follows:

Year	Funding (£)
1999-2000	3,660,000
2000-01	3,059,000
2001-02	3,398,100
2002-03	3,552,921
2003-04	3,515,958
2004-05	3,515,958

 

All of the funding wastargeted at regeneration.

The SIP fund has beenreplaced by the Community Regeneration Fund from April 2005.

The regulation and safety ofmedicines are reserved and are the responsibility of the Medicines andHealthcare products Regulatory Agency (MHRA). The MHRA and the Commission onHuman Medicines run the UK’s spontaneous adverse drug reaction reportingscheme, the Yellow Card Scheme.Guidelines on reporting ofadverse drug reactions through the Yellow Card Scheme are provided to healthprofessionals in the British National Formulary. Health professionals(including doctors, dentists, coroners, pharmacists and nurses) are asked toreport suspected adverse reactions to any therapeutic agents, both prescribedproducts and those available over the counter, including herbal products.Detailed guidelines for health professionals and patients on what to report andhow to report suspected adverse reactions are available at www.yellowcard.gov.uk.This website also contains an electronic Yellow Card form for reporting ofsuspected adverse reactions.